Antitumor Activity of Vinflunine: Effector Pathways and Potential for Synergies
Authors:
- 1 June 2008
- journal article
- review article
- Published by Elsevier in Seminars in Oncology
- Vol. 35, S13-S21
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Higher antitumor activity of vinflunine than vinorelbine against an orthotopic murine model of transitional cell carcinoma of the bladderUrologic Oncology: Seminars and Original Investigations, 2002
- Vinflunine, the latest Vinca alkaloid in clinical developmentCritical Reviews in Oncology/Hematology, 2001
- The effect of antimicrotubule agents on signal transduction pathways of apoptosis: a reviewCancer Chemotherapy and Pharmacology, 1999
- Superior in vivo experimental antitumour activity of vinflunine, relative to vinorelbine, in a panel of human tumour xenograftsEuropean Journal of Cancer, 1999
- Involvement of Microtubules in the Regulation of Bcl2 Phosphorylation and Apoptosis through Cyclic AMP-Dependent Protein KinaseMolecular and Cellular Biology, 1998
- Preclinical in vivo antitumor activity of vinflunine, a novel fluorinated Vinca alkaloidCancer Chemotherapy and Pharmacology, 1998
- Antimitotic and tubulin-interacting properties of vinflunine, a novel fluorinated Vinca alkaloidBiochemical Pharmacology, 1998
- Vinorelbine Induces Apoptosis and Caspase-3 (CPP32) Expression in Leukemia and Lymphoma Cells: A Comparison with VincristineLeukemia & Lymphoma, 1998
- The role of the Caspase family of cysteine proteases in apoptosisSeminars in Immunology, 1997
- Apoptosis: an overviewBritish Medical Bulletin, 1997